Table 1

Baseline patient characteristics*

FemaleMale
Placebo
(N=23)
GSK2881078
(N=24)
Placebo
(N=24)
GSK2881078
(N=25)
Age, mean (SD), years64.7 (7.16)64.2 (7.93)64.0 (7.27)67.2 (6.08)
Ethnicity, n (%)
 Black or African American01 (4)2 (8)2 (8)
 White/Caucasian/European23 (100)23 (96)22 (92)23 (92)
BMI (kg/m2), mean (SD)23.9 (3.93)24.2 (3.78)25.5 (4.22)26.0 (4.51)
Postbronchodilator FEV1 % predicted, mean (SD)46.2 (10.82)49.6 (9.69)51.2 (10.63)48.0 (11.80)
  • *Baseline characteristics for the all randomised subjects who receive at least one dose of study medication.

  • BMI, body mass index; FEV1, forced expiratory volume in 1 s.;